Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer
A new study led by Yale Cancer Center (YCC) researchers shows women with high-risk HER2-negative breast cancer treated before surgery with immunotherapy, plus a PARP inhibitor with chemotherapy, have a higher rate of complete ...
Apr 28, 2020
0
33